Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Radionics' immobilisation device:

This article was originally published in Clinica

Executive Summary

Radionics has received US 510(k) marketing clearance for its device for immobilising and localising patients undergoing stereotactic radiation therapy treatments. The Body System device, which is used with Radionics' XPlan and IMRT (Intensity Modulated Radiation Therapy) treatment planning system, makes it possible to reproduce the set-up of the patient receiving fractionated treatments and align the radiation beam precisely to the tumour volume. This allows the tumour to be treated effectively while sparing the surrounding tissue, says the company, a division of Tyco Healthcare.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel